LuoXin Innovate

LXI-15028 · Shandong Luoxin Pharmaceutical Group Stock Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for LuoXin Innovate, covering 2018-05-30 to 2018-05-30. Get the full timeline:

Most recent: Clinical Trial Update: A Phase I Study of LuoXin Innovate (LXI-15028) in Healthy Chinese Subjects to Evaluate the Pharmacokinetics, Safety and Tolerability. [Phase 1]

See pricing